Previous 10 | Next 10 |
Hoth Therapeutics Announces FDA Accepts Pre-Investigational New Drug (Pre-IND) Submission for HT-KIT, Treatment for Cancer Patients PR Newswire HT-KIT received Orphan Drug Designation from FDA for its mRNA Frame Shifting Cancer Therapeutic Hoth intends to initially...
Hoth Therapeutics Announces Positive Final Results from 14-day Phase 1b Clinical Trial of BioLexa PR Newswire 78% of patients reported that their overall health had improved since starting BioLexa as compared to 22% stating that there was no change in their health, or their he...
2023-08-10 08:25:22 ET Galera Therapeutics ( GRTX ) -82% . Origin Materials ( ORGN ) -57% after Q2 earning release . Organogenesis Holdings ( ORGO ) -32% after Q2 earning release . Renovaro Biosciences ( RENB ) -23% . Wolverine World...
2023-08-09 10:51:01 ET Results from a preclinical study of Hoth Therapeutics' ( NASDAQ: HOTH ) HT-ALZ for Alzheimer's disease found that the candidate led to improvement in areas of cognitive function. More specifically, benefits were seen with spatial learning and memory, sen...
Hoth Therapeutics Announces Positive Preclinical End Point Results of HT-ALZ Treatment for Alzheimer's Disease PR Newswire HT-ALZ Showed Improvement on Several Tests of Cognitive Function HT-ALZ Showed Positive Benefits with Reductions in Anxiety Completed Dose Res...
Hoth Therapeutics Announces Major Milestone of First Patient Dosed in Phase 2a Clinical Trial PR Newswire NEW YORK , July 25, 2023 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced today that the ...
Hoth Therapeutics Receives Protocol Approval for HT-001 Cancer Therapeutic PR Newswire FDA Approved Trial Now Has Two Sites Approved with Additional Sites in Approval Process Recruitment of Patients to Accelerate NEW YORK , July 19, 2023 /PRNewswi...
Hoth Therapeutics Announces IRB Approval for FDA Cleared First-In-Human Clinical Trial of HT-001 at Second Clinical Site PR Newswire Hoth achieves milestone of multiple sites to host trial NEW YORK , June 14, 2023 /PRNewswire/ -- Hoth Therapeutics, Inc. (...
2023-06-07 08:27:22 ET United Natural Foods ( UNFI ) -24% after Q3 earning release , Mondee Holdings ( MOND ) -24% announces pricing of secondary offering of common stock by selling stockholders. Vaxart ( VXRT ) -23% announces proposed public offe...
2023-06-06 13:11:07 ET Gainers: Recruiter.com Group ( RCRT ) +135% . Hoth Therapeutics ( HOTH ) +79% . Beamr Imaging ( BMR ) +32% . GitLab ( GTLB ) +31% . D-Wave Quantum ( QBTS ) +27% . MicroVision ( MVIS ) +23% . ...
News, Short Squeeze, Breakout and More Instantly...
Hoth Therapeutics Inc. Company Name:
HOTH Stock Symbol:
NYSE Market:
Hoth Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...
Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment PR Newswire Treatment of pre-clinical subjects showed cognitive benefits that suggest HT-ALZ's mode of action may involve a reduction in brain inflammation, thereby improving cognitiv...
Hoth Therapeutics Expands Clinical Trial for Cancer Patients PR Newswire Three New Sites Join HT-001 Trial, GW University Hospital, UC Irvine and Northwell Health NEW YORK , July 16, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH ), a ...